This study characterized the enzymatic degradation of ACTH(4-10) and Semax by rat blood enzymes, focusing on N-terminal processing. Understanding the peptide's stability and metabolism in blood is important for optimizing its pharmacokinetic profile and therapeutic dosing.
Potaman, V N; Alfeeva, L Y; Kamensky, A A; Levitzkaya, N G; Nezavibatko, V N